Gavi-supported yellow fever vaccine campaigns in 14 African countries have protected over 98 million people
Yellow fever vaccine introduced in routine immunisation systems in 17 countries in Africa
Over 52 million doses from the emergency stockpile have reached Gavi-supported countries experiencing yellow fever outbreaks
Nigeria, which is highly yellow fever endemic, has introduced the vaccine into the routine system and conducted vaccination campaigns with support from Gavi. Credit: Gavi/2013/Adrian Brooks.
Yellow fever vaccine is highly effective: a single dose leads to long-term, probably even lifelong, immunity in 99% of people vaccinated.
Gavi has invested more than US$ 300 million in yellow fever control since 2001, focusing on African countries where the vast majority of yellow fever deaths occur. The Vaccine Alliance funds routine vaccine introductions, an emergency stockpile and preventive vaccination campaigns.
Gavi’s support is closely aligned with WHO's Eliminate Yellow Fever Epidemics (EYE) Strategy, which aims to coordinate yellow fever control at the global level. With more than 50 partners involved, the EYE partnership supports 40 at-risk countries in Africa and the Americas to prevent, detect, and respond to yellow fever suspected cases and outbreaks.
LIFE-SAVING PREVENTIVE CAMPAIGNS
Since 2011, Gavi-supported prevention campaigns have been organised in 14 countries in Africa, protecting more than 98 million people in Benin, Burkina Faso, Cameroon, the Central African Republic, Côte d’Ivoire, Ghana, Guinea, Liberia, Mali, Nigeria, Senegal, Sierra Leone, the Sudan and Togo.
Yellow fever campaigns together with routine immunisation programmes supported by Gavi have averted over 500,000 deaths since 2010. The campaigns have significantly reduced the risk of yellow fever outbreaks in Africa.
However, rapid urbanisation and environmental changes are shifting the geography of yellow fever, and the virus is now affecting areas previously considered non-endemic. Recent yellow fever epidemics, which have spread outside of Africa, underline the continued global threat posed by yellow fever.
Due to the continued risk of outbreaks, coupled with the improved supply situation for the vaccine, Nigeria decided to resume its phased preventive yellow fever vaccination campaign in 2017. Nigeria has also developed a long-term yellow fever control plan, which is closely aligned with the WHO’s EYE strategy.
ROUTINE IMMUNISATION IN 17 COUNTRIES – BUT COVERAGE REMAINS LOW
Despite the success of mass campaigns, challenges remain. The low routine yellow fever immunisation coverage across Gavi-supported countries is of concern, averaging out at about 36% in 2017. For example, in Nigeria, where yellow fever is highly endemic, routine immunisation coverage stood at just 39% in 2017.1
Four high-risk countries (Ethiopia, South Sudan, Sudan and Uganda) have yet to introduce the vaccine into their routine systems. In addition, surveillance and diagnostics systems, which play a key role in early detection and optimal vaccination response, are insufficient in many yellow fever-endemic countries.
EMERGENCY STOCKPILE RESPONDS TO OUTBREAKS
Several outbreaks of yellow fever occurred in 2017, most notably in Brazil and Nigeria, which prompted both countries to access vaccine doses through the Gavi-funded stockpile.
The International Coordination Group (ICG), with the support of Gavi, has deployed millions of doses of the yellow fever vaccine worldwide in response to outbreaks. The ICG includes representatives from WHO, UNICEF, Médecins sans Frontières, and the International Federation of Red Cross and Red Crescent Societies.
In the event of an outbreak, Gavi-supported countries can request vaccines from the stockpiles free of charge. Other countries can access Gavi-funded stockpile vaccines but are required to reimburse the cost of the vaccines once the outbreak has come to an end. Financial support is also available to help the planning and implementation of emergency vaccination campaigns. For more details, visit www.who.int/csr/disease/yellowfev/global_partnership/en/.